Skip to main content

Advertisement

Table 4 The Post-hoc analysis (least significant difference) comparing IGFBP-3 serum levels for each of the 6 CVMI stages

From: Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators

CVMI Stage CVMI stage Mean Difference Significance
1 2 -516.1 0.240(NS)
3 -1896.9* 0.000(**)
4 -2130.8* 0.000(**)
5 -928.1* 0.036(*)
6 -543.5 0.216(NS)
2 1 516.1 0.240(NS)
3 -1380.8* 0.002(**)
4 -1614.6* 0.000(**)
5 -411.9 0.347(NS)
6 -27.4 0.950(NS)
3 1 1896.9* 0.000(**)
2 1380.8* 0.002(**)
4 -233.8 0.593(NS)
5 968.8* 0.029(**)
6 1353.4* 0.003(**)
4 1 2130.8* 0.000(**)
2 1614.6* 0.000(**)
3 233.8 0.593(NS)
5 1202.7* 0.007(**)
6 1587.2* 0.000(**)
5 1 928.1* 0.036(*)
2 411.9 0.347(NS)
3 -968.8* 0.029(*)
4 -1202.7* 0.007(**)
6 384.5 0.380(NS)
6 1 543.5 0.216(NS)
2 27.4 0.950(NS)
3 -1353.4* 0.003(**)
4 -1587.2* 0.000(**)
5 -384.5 0.380(NS)
  1. (**) Highly significant (P < 0.01, P < 0.001), (*)Significant (P < 0.05)
  2. NS Not Significant